Masten L W
Drug Alcohol Depend. 1980 Feb;5(2):87-100. doi: 10.1016/0376-8716(80)90185-4.
Induction of hepatic propoxyphene N-demethylase and aniline hydroxylase activities resulted following repeated oral administration of 25, 50 and 100 mg d-propoxyphene hydrochloride per kg daily in the mouse over a six-day period. A significant elevation in both enzyme activities was noted after a single dose of propoxyphene (100 mg/kg). A dose-related response characterized the observed induction of each microsomal enzyme activity. Pentobarbital sleeping times (a measure of in vivo microsomal activity) also exhibited dose-related decrements in hypnosis with increasing doses of propoxyphene. These effects appeared to correlate with the development of tolerance to both the analgesic and lethal properties of propoxyphene. Pretreatment with SKF-525A, a potent microsomal enzyme inhibitor, abolished this tolerance in each case. Furthermore, a lack of central nervous system cellular tolerance was demonstrated by the finding that intracerebroventricular LD50 values for propoxyphene in propoxyphene- and water-treated mice were identical to the value derived from naive mice. Thus, the observed tolerance seems to be the result of dispositional (metabolic) and not central nervous system tolerance.
在小鼠中,连续六天每天口服25、50和100毫克/千克盐酸右丙氧芬后,诱导了肝脏丙氧芬N-脱甲基酶和苯胺羟化酶的活性。单次给予丙氧芬(100毫克/千克)后,两种酶的活性均显著升高。观察到的每种微粒体酶活性的诱导呈现出剂量相关的反应。戊巴比妥睡眠时间(体内微粒体活性的一种测量指标)也随着丙氧芬剂量的增加而呈现出与剂量相关的催眠作用减弱。这些效应似乎与对丙氧芬的镇痛和致死特性的耐受性发展相关。用强效微粒体酶抑制剂SKF-525A进行预处理,在每种情况下都消除了这种耐受性。此外,通过发现丙氧芬处理组和水处理组小鼠中丙氧芬的脑室内LD50值与未处理小鼠得出的值相同,证明不存在中枢神经系统细胞耐受性。因此,观察到的耐受性似乎是处置性(代谢性)的结果,而非中枢神经系统耐受性的结果。